CDC Backs Boosters for High-Risk Kids Aged 5-11, Shorter Time Between Shots
TUESDAY, Jan. 4, 2022 (HealthDay News) — The U.S. Centers for Disease Control and Prevention on Tuesday backed the emergency use approval of Pfizer’s booster shot for high-risk kids between the ages of 5 and 11, along with shortening the time period between a second dose and a booster shotContinue Reading